The global Tissue Diagnostic Market is valued at USD 8.81 billion in 2024 and is projected to reach a value of USD 19.01 ...

Only with the adoption of digital imaging and AI-powered analysis will next-generation precision oncology therapies reach their full potential and ensure no eligible patient is overlooked.

What's driving the shift to spatially resolved molecular analysis? The global in situ hybridization market, valued at USD ...

Emrill, a leading UAE-based total facilities management provider, has reported a significant increase in residential ...

Emrill, a leading UAE-based total facilities management provider, has reported a significant increase in residential ...

What's driving the shift to spatially resolved molecular analysis? The global in situ hybridization market, valued at USD 1.64 billion ...

Objective: Molecular subtyping is an important procedure for prognosis and targeted therapy of breast carcinoma, the most common type of malignancy affecting women. Immunohistochemistry (IHC) analysis ...

The Human Epidermal Growth Factor Receptor 2 (HER2) is one of the aggressive subtypes of breast cancer. The HER2 status decides the requirement of breast cancer patients to receive HER2-targeted ...

Steak houses have been on the dining landscape for generations, with that timelessness that continues and draws food enthusiasts year in, year out. Whether a special night, a business dinner meeting, ...

The Japanese tissue diagnostics market is projected to climb to US$ 234 Million by 2030, driven by aging demographics and increasing prevalence of chronic diseases. Key market innovations include ...

International Holding Company (IHC) officially named its new global reinsurance platform as Reinsurance Intelligence Quotient (RIQ). The new entity is headquartered in Abu Dhabi Global Market ...